| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Center for Reproductive Biology, School of Molecular Biosciences (M.D.A., M.K.S.), Veterinary Microbiology and Pathology (C.L.), Washington State University, Pullman, Washington 99164-4231
Address all correspondence and requests for reprints to: Michael K. Skinner, Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, Washington 99164-4231. E-mail: skinner{at}mail.wsu.edu.
The fetal basis of adult disease is poorly understood on a molecular level and cannot be solely attributed to genetic mutations or a single etiology. Embryonic exposure to environmental compounds has been shown to promote various disease states or lesions in the first generation (F1). The current study used the endocrine disruptor vinclozolin (antiandrogenic compound) in a transient embryonic exposure at the time of gonadal sex determination in rats. Adult animals from the F1 generation and all subsequent generations examined (F1F4) developed a number of disease states or tissue abnormalities including prostate disease, kidney disease, immune system abnormalities, testis abnormalities, and tumor development (e.g. breast). In addition, a number of blood abnormalities developed including hypercholesterolemia. The incidence or prevalence of these transgenerational disease states was high and consistent across all generations (F1F4) and, based on data from a previous study, appears to be due in part to epigenetic alterations in the male germ line. The observations demonstrate that an environmental compound, endocrine disruptor, can induce transgenerational disease states or abnormalities, and this suggests a potential epigenetic etiology and molecular basis of adult onset disease.
This article has been cited by other articles:
![]() |
T. C. King Heiden, J. Spitsbergen, W. Heideman, and R. E. Peterson Persistent Adverse Effects on Health and Reproduction Caused by Exposure of Zebrafish to 2,3,7,8-Tetrachlorodibenzo-p-dioxin During Early Development and Gonad Differentiation Toxicol. Sci., May 1, 2009; 109(1): 75 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Foster Environmental Estrogens and Endocrine Disruption: Importance of Comparative Endocrinology Endocrinology, September 1, 2008; 149(9): 4267 - 4268. [Full Text] [PDF] |
||||
![]() |
E. E Nilsson, M. D Anway, J. Stanfield, and M. K Skinner Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease Reproduction, May 1, 2008; 135(5): 713 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yauk, A. Polyzos, A. Rowan-Carroll, C. M. Somers, R. W. Godschalk, F. J. Van Schooten, M. L. Berndt, I. P. Pogribny, I. Koturbash, A. Williams, et al. Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location PNAS, January 15, 2008; 105(2): 605 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Crews, A. C. Gore, T. S. Hsu, N. L. Dangleben, M. Spinetta, T. Schallert, M. D. Anway, and M. K. Skinner Transgenerational epigenetic imprints on mate preference PNAS, April 3, 2007; 104(14): 5942 - 5946. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Price, S. K. Murphy, and E. V. Younglai Perspectives: The Possible Influence of Assisted Reproductive Technologies on Transgenerational Reproductive Effects of Environmental Endocrine Disruptors Toxicol. Sci., April 1, 2007; 96(2): 218 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Zoeller Endocrine Disruptors: Do Family Lines Carry an Epigenetic Record of Previous Generations' Exposures? Endocrinology, December 1, 2006; 147(12): 5513 - 5514. [Full Text] [PDF] |
||||
![]() |
H.-S. Chang, M. D. Anway, S. S. Rekow, and M. K. Skinner Transgenerational Epigenetic Imprinting of the Male Germline by Endocrine Disruptor Exposure during Gonadal Sex Determination Endocrinology, December 1, 2006; 147(12): 5524 - 5541. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |